Home Editor's Picks Pfizer, Salesforce and Darden Restaurants Rise Premarket; Rite Aid Falls

Pfizer, Salesforce and Darden Restaurants Rise Premarket; Rite Aid Falls

by
Stock Markets2 hours ago (Sep 23, 2021 07:57AM ET)

(C) Reuters

By Peter Nurse

Investing.com — Stocks in focus in premarket trade on Thursday, September 23rd. Please refresh for updates.

Pfizer (NYSE:PFE) stock rose 0.8% after the Food and Drug Administration approved the drugmaker’s booster shots of its Covid-19 vaccine for older people and other vulnerable Americans.

Darden Restaurants (NYSE:DRI) stock rose 4.2% after the owner of Olive Garden and Longhorn Steakhouse reported strong first-quarter results and raised its 2022 outlook, as well declaring a quarterly dividend and an additional $750 million stock buyback.

Rite Aid (NYSE:RAD) stock fell 3.8% after the chain of pharmacies reported a hefty second quarter net loss from continuing operations of over $100 million, even as the company raised its full-year earnings guidance.

Salesforce (NYSE:CRM) stock rose 2.3% following the software company lifting its full-year revenue outlook and offering up upbeat 2023 guidance.

Facebook (NASDAQ:FB) stock rose 0.7%, rebounding after Wednesday’s 4% loss, following comments from marketing head Graham (NYSE:GHM) Mudd that the social media giant is under-reporting the results of its business on Apple (NASDAQ:AAPL) devices. This lessened worries associated with changes to the iPhone maker’s privacy rules.

Blackberry (TSX:BB) stock rose 8% after the handheld device maker, and occasional meme favorite, reported better-than-expected second-quarter results, helped by demand for Internet of Things solutions.

Biogen (NASDAQ:BIIB) stock rose 0.8% on the back of investment firm Needham sticking with its ‘buy’ rating for the biotech company, saying the stock market has not priced in the potential upside for new drugs.

HB Fuller (NYSE:FUL) stock rose 2.7% after the chemicals company reported better-than-expected organic revenue growth, climbing by double digits.

Roku (NASDAQ:ROKU) stock rose 2.8%, helped by Guggenheim upgrading its investment stance to ‘buy’ from ‘neutral’, citing the streaming hardware company’s inroads into the international market.

Pfizer, Salesforce and Darden Restaurants Rise Premarket; Rite Aid Falls

Wall Street Opens Higher as Jobless Claims Bolster Fed Hopes; Dow up 420 Pts
By Investing.com – Sep 23, 2021

By Geoffrey Smith
Investing.com — U.S. stock markets opened higher on Thursday, extending Wednesday’s gains on growing hopes that China can avoid a messy deleveraging of its real…

Novavax applies to WHO for emergency listing of COVID-19 vaccine
By Reuters – Sep 23, 2021

(Reuters) -Novavax Inc and its partner Serum Institute of India have applied to the World Health Organization for an emergency use listing of Novavax (NASDAQ:NVAX)’s COVID-19…

Wall Street opens higher as taper fears ease
By Reuters – Sep 23, 2021

(Reuters) – U.S. stocks opened higher on Thursday as investors largely brushed off concerns over the Federal Reserve’s plans for tapering, while forecast raises from Accenture…

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Our Apps

Terms And Conditions
Privacy Policy
Risk Warning

(C) 2007-2021 Fusion Media Limited. All Rights Reserved

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Related News